Gvoke hypopen 2-PK 1 MG/0.2 ML 0.2ML
Ended Awarded
- Contract number
- SPE2DB25FWKSZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,808
Award facts
- Contract value 100% obligated
- $1,808.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,808.10 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 ml) auto-injectors. This firm fixed-price, competitively awarded contract was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of contract awards with the DLA Medical Supply Chain. The company's federal contract performance demonstrates consistent capability in delivering diverse pharmaceutical products across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing. GVOKE HypoPen auto-injectors are glucagon emergency treatment devices used for severe hypoglycemia, reflecting AmerisourceBergen's role in supplying critical medical supplies and specialty medications to support military personnel and veteran healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FWKSZ?
SPE2DB25FWKSZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FWKSZ worth?
The government has obligated $1,808 on SPE2DB25FWKSZ.
Is contract SPE2DB25FWKSZ an order under another contract?
Yes. SPE2DB25FWKSZ is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWKSZ competed?
The extent of competition for SPE2DB25FWKSZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award